Title: Respiratory Diagnostics Market Overview, Growth, Share, Revenue and Forecast 2017-2024
1Respiratory Disease Testing Market size is
projected to experience significant growth from
2017 to 2024. Global Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
Low Power Wide Area Network
2Regional Analysis of Respiratory Disease Testing
Market
- Respiratory disease testing market should witness
substantial growth due to increased prevalence of
respiratory diseases such as chronic obstructive
pulmonary disease (COPD) and asthma over the last
few years. - Increasing pollution and tobacco consumption
coupled with rising geriatric population base and
technological advancement in respiratory devices
should drive respiratory disease testing market
size over the forecast period. - According to the International Respiratory
Societies Forum, in 2014, over 200 million people
across the world had COPD and nearly 235 million
people were suffering from asthma. Furthermore,
over 50 million individuals struggle with
occupational lung disorder every year. - These factors should drive respiratory disease
testing market growth. Increasing healthcare
expenses and reimbursement concern may restrain
the industry growth during the forecast period.
Low adoption rate of portable spirometers and
digital radiography can also hinder the
respiratory disease testing market size.
3- Imaging tests includes x-rays, computed
tomography (CT), magnetic resonance imaging,
nuclear scanning, ultrasonography, and positron
emission tomography (PET) scanning. Chest x-rays
provide detailed framework of the heart and major
blood vessels, it can also reveal serious
disorder in the lungs and chest wall. - Chest x-ray reveal chronic obstructive pulmonary
disease, pneumonias, atelectasis, lung tumors and
pneumothorax or pleural effusion in the pleural
space. It helps doctors to determine other tests
required for the diagnosis. Measurement devices
include respirometers, spirometers, capnographs,
pulse oximeters and peak flowmeters. - Demand for pulse oximeters is rising in
comparison with other devices due to precise and
effective diagnosis in short time and increasing
adoption for these testing devices by physicians.
4Competitive Market Share of Respiratory Disease
Testing Market
- Insulin market estimated to foresee lucrative
growth due to rising awareness about product and
self-administration of insulin coupled with
favorable reimbursement policies. - GLP-1 therapy will witness healthy growth in
future due to its ability to minimize blood
glucose level in patients with target disease.
Homecare will be the major end user of the pen
needles owing to self-administration of insulin
on daily basis. - Hospital segment is anticipated to witness
healthy growth in the coming few years due to
availability of highly-skilled professionals and
the quality of patient care provided.
5 Browse Full Market Research Report On
Respiratory Disease Testing Market_at_
http//bit.ly/2uuKfIR Request for an in-depth
table of contents for this report _at_
http//bit.ly/2tPdW4E
6Stay In Touch Website www.gminsights.com Soci
al Media